Ensitrelvir, marketed as Xocova, works by inhibiting viral replication and is designed as a 5-day oral protective regimen, ...
OSAKA, Japan, June 01, 2026--(BUSINESS WIRE)--Shionogi & Co., Ltd. (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter "Shionogi") announced that the U.S. Food and ...
A research team at Ruhr University Bochum, Germany, has identified a previously unknown cellular mechanism crucial to the replication of coronaviruses: c-Jun N-terminal kinase (JNK) is activated ...
Hyundai Bioscience announced on May 20th that XAFTY® has a strong likelihood of being able to treat Ebola and Hantavirus given its low IC50 (50% inhibitory concentration) for those viruses. Amid the ...
The deadly outbreak of hantavirus on a cruise ship has led some to suggest that ivermectin could be used to treat an infection.
In a major expansion of the pandemic treatment toolkit, the U.S. Food and Drug Administration (FDA) has officially approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results